TAS-119

tas-119 · Taiho Oncology, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TAS-119, covering 2024-09-04 to 2024-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors [Phase 1]

See pricing